RealSeq Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5M

  • Investors
  • 17

RealSeq Biosciences General Information

Description

Developer of RNA fragmentomics technology designed to offer real-time detection of disease for improving diagnosis and treatment. The company's technology is used for biomarker discovery, liquid biopsy, and single-cell analysis in the fields of cancer and infectious diseases, and bioinformatics for analyzing degradation, splicing, mutations, and modifications, enabling clients to improve patient outcomes through innovative RNA-based services.

Contact Information

Website
www.realseq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2125 Delaware Avenue
  • Suite B
  • Santa Cruz, CA 95060
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • 2125 Delaware Avenue
  • Suite B
  • Santa Cruz, CA 95060
  • United States

RealSeq Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RealSeq Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 01-Mar-2024 $5M Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
4. Grant 13-Oct-2023 Completed Generating Revenue
3. Accelerator/Incubator 01-Jun-2022 Completed Generating Revenue
2. Grant 01-Jan-2018 $2.02M Completed Startup
1. Grant 01-Jan-2019 $2.6M Completed Startup
To view RealSeq Biosciences’s complete valuation and funding history, request access »

RealSeq Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of RNA fragmentomics technology designed to offer real-time detection of disease for improving diagnosis and t
Diagnostic Equipment
Santa Cruz, CA
9 As of 2024

Palo Alto, CA
 

Shirley, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RealSeq Biosciences Competitors (2)

One of RealSeq Biosciences’s 2 competitors is Exai Bio, a Venture Capital-Backed company based in Palo Alto, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exai Bio Venture Capital-Backed Palo Alto, CA
CD Genomics Corporation Shirley, NY
You’re viewing 2 of 2 competitors. Get the full list »

RealSeq Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RealSeq Biosciences Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel Star Ventures Angel Group Minority
Berkeley Angel Network Angel Group Minority
Charleston Angel Partners Angel Group Minority
Chemical Angel Network Angel Group Minority
MEDA Angels Angel Group Minority
You’re viewing 5 of 17 investors. Get the full list »

RealSeq Biosciences FAQs

  • When was RealSeq Biosciences founded?

    RealSeq Biosciences was founded in 2019.

  • Where is RealSeq Biosciences headquartered?

    RealSeq Biosciences is headquartered in Santa Cruz, CA.

  • What is the size of RealSeq Biosciences?

    RealSeq Biosciences has 9 total employees.

  • What industry is RealSeq Biosciences in?

    RealSeq Biosciences’s primary industry is Diagnostic Equipment.

  • Is RealSeq Biosciences a private or public company?

    RealSeq Biosciences is a Private company.

  • What is RealSeq Biosciences’s current revenue?

    The current revenue for RealSeq Biosciences is .

  • How much funding has RealSeq Biosciences raised over time?

    RealSeq Biosciences has raised $5M.

  • Who are RealSeq Biosciences’s investors?

    Angel Star Ventures, Berkeley Angel Network, Charleston Angel Partners, Chemical Angel Network, and MEDA Angels are 5 of 17 investors who have invested in RealSeq Biosciences.

  • Who are RealSeq Biosciences’s competitors?

    Exai Bio and CD Genomics are competitors of RealSeq Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process